Screener
Gyre Therapeutics, Inc. GYRE All Other Segments — Total Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Deferred tax assets | 9,284 | 6,873 |
| Long-term certificates of deposit | 28,444 | 23,516 |
| Other assets, noncurrent | 7,344 | 7,624 |
| Total assets | $199,255 | $219,763 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $1,236 | $1,335 |
| Due to related parties | 5,085 | 227 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s all other segments — total assets?
- Gyre Therapeutics, Inc. (GYRE) reported all other segments — total assets of $357K in Q2 2026.
- How has Gyre Therapeutics, Inc.'s all other segments — total assets changed year-over-year?
- Gyre Therapeutics, Inc.'s all other segments — total assets decreased by 2.2% year-over-year, from $365K to $357K.
- What does all other segments — total assets mean?
- This metric represents the total value of assets specifically identified and allocated to the 'All Other Segments' business unit. It provides insight into the capital intensity and resource deployment required to support these non-core business activities. Investors use this to evaluate the asset base supporting the segment's operations.
Ask your AI about Gyre Therapeutics, Inc.'s all other segments — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude